Mycobacterium tuberculosis TB15.3 interactors
Ontology highlight
ABSTRACT:
ORGANISM(S): Mycobacterium Tuberculosis H37rv
SUBMITTER: Tiago Beites
PROVIDER: PXD065910 | JPOST Repository | Tue Jul 08 00:00:00 BST 2025
REPOSITORIES: jPOST
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| Flag%20control_1.raw | Raw | |||
| Flag%20control_2.raw | Raw | |||
| Flag%20control_3.raw | Raw | |||
| TB15.3%20pulldown%20MS%20results.xlsx | Xlsx | |||
| TB15.3_1.raw | Raw |
Items per page: 5 1 - 5 of 10 |
Similar Datasets
Project description:Cyanobacterial identification by native mass spectrometry
| PRJEB45336 | ENA
Project description:Here using a high-throughput yeast two-hybrid and mass spectrometry approach we show that mycobacterial proteins can access the RNA splicing machinery of the host, thereby playing a critical role in infection-induced perturbation of alternative splicing.
2025-03-31 | GSE223916 | GEO
Project description:Mtb was grown as either an actively growing normal culture or as a hypoxia-induced dormant culture. Whole cell lysates of live bacteria were obtained by mechanical disruption with silica beads. ATP-binding proteins were covalently labeled with desthiobiotin-tagged ATP (ActivX, Thermo Pierce). This chemoproteomic approach profiled the ATP-binding proteins present in either metabolic state. Labeled proteins were enriched via streptavidin affinity chromatography, digested with trypsin and subjected to tandem mass spectrometry (LC-MS/MS) for the identification of proteins containing a desthiobiotin modification of lysine (K +196 Da). Differential abundance of nucleotide binding proteins between the two growth conditions were quantified using label-free spectral counting and normalized spectral abundance factors (NSAF). DATABASE SEARCHING: Tandem mass spectra were extracted, charge state deconvoluted and deisotoped by Xcalibur version 2.2 SP1. All MS/MS samples were analyzed using Mascot (Matrix Science, London, UK; version 2.3.02) and SEQUEST (Thermo Fisher Scientific, San Jose, CA, USA; version v.27, rev. 11). Mascot and SEQUEST were set up to search the MtbReverse041712 database (7992 entries) assuming the digestion enzyme Trypsin. Parameters for both search engines were set to a fragment ion mass tolerance of 1.0 Da and a parent ion tolerance of 2.5 Da. Oxidation of methionine, iodoacetamide derivative of cysteine and the desthiobiotin modification of lysine were specified in Mascot and SEQUEST as variable modifications. PROTEIN IDENTIFICATION AND LABEL-FREE QUANTITATION-- Scaffold (version Scaffold_3.6.1, Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein identifications. Peptide identifications were accepted if they exceeded specific database search engine thresholds. Mascot identifications required ion scores to be greater than the associated identity scores and 50, 65, 65 and 65 for singly, doubly, triply and quadruply charged peptides. SEQUEST identifications required deltaCn scores of greater than 0.2 and XCorr scores of greater than 1.8, 2.0, 3.0 and 4.0 for singly, doubly, triply and quadruply charged peptides. Proteins identifications were accepted if they contained at least one identified peptide in at least two biological replicates. Peptide spectra meeting the most minimum requirement were manually inspected for quality. Quantification of proteins was performed on normalized spectral abundance factors for each protein (NSAF). BLAST-BASED SEQUENCE DESCRIPTION: The most relevant description for each of the sequences was acquired based on the significant BLAST results. The homologs for the sequences were retrieved using the Blastp algorithm and the nonredundant database of NCBI. The Blast2GO suite was used. GENE ONTOLOGY ANNOTATION: The Pfam domains were mapped to Gene Ontology (GO) terms using the lookup table provided by Pfam2go (http://www.geneontology.org/external2go/pfam2go). An in-house script was written to retrieve GO annotations based on the root term as "molecular function" and their distance from the root term. PFAM DOMAIN-BASED ANNOTATION: The InterPro and Pfam IDs corresponding to the GO term "ATP binding" (GO ID:0005524) were retrieved using the QuickGO (www.ebi.ac.uk/QuickGO/<http://www.ebi.ac.uk/QuickGO/>) and InterPro BioMart web services (http://www.ebi.ac.uk/interpro/biomart/martview). The ATP-binding associated domains were queried against the ATP-binding proteome data sets according to spectral quality (high, medium, low confidence). Their Pfam and InterPro descriptions, were identified using the InterProscan Web service, which was accessed via the Pipeline Pilot (Accelrys) implementation in the sequence analysis collection.
2013-04-08 | PXD000141 | Pride
Project description:Mycobacterium tuberculosis: Control Vs db-cAMP treated cells
| PRJNA236135 | ENA
Project description:Transcriptional profiling of Mycobacterium tuberculosis CDC1551 comparing control butyric acid-treated cells with 20mM db-cAMP treated cells after 2hrs of treatment with shaking at 200rpm at 37C. Two-condition experiment, butyric acid (Control) Vs db-cAMP treated cells (Test). Biological replicates: 3 control, 3 test. One replicate per array.
2014-01-23 | E-GEOD-54289 | biostudies-arrayexpress
Project description:Transcriptional profiling of Mycobacterium tuberculosis CDC1551 comparing control butyric acid-treated cells with 20mM db-cAMP treated cells after 2hrs of treatment with shaking at 200rpm at 37C.
2014-01-23 | GSE54289 | GEO
Project description:In this study, screening efforts identified novel antifolates with potent, targeted activity against whole cell Mycobacterium tuberculosis. Liquid chromatography-mass spectrometry analysis of antifolate-treated cultures revealed unique metabolic disruption, including decreased pools of methionine and S-adenosylmethionine. Transcriptomic analysis highlighted up-regulation genes involved in the biosynthesis and utilization of methionine. Supplementation with amino acids or methionine derivatives was sufficient to rescue cultures from MIC-level antifolate treatment. Instead of the “thymineless death” that characterizes folate pathway inhibition in a wide variety of organisms, these data suggest that M. tuberculosis is vulnerable to a critical disruption of the biosynthesis of methionine-derived compounds. These arrays look at the expression profile triggered by exposure to three different anti-folates (WR99210, dimethyl and diethyl methotrexate) in three biological replicates and in a matched set of untreated samples.
2014-03-19 | E-GEOD-55979 | biostudies-arrayexpress
Project description:In this study, screening efforts identified novel antifolates with potent, targeted activity against whole cell Mycobacterium tuberculosis. Liquid chromatography-mass spectrometry analysis of antifolate-treated cultures revealed unique metabolic disruption, including decreased pools of methionine and S-adenosylmethionine. Transcriptomic analysis highlighted up-regulation genes involved in the biosynthesis and utilization of methionine. Supplementation with amino acids or methionine derivatives was sufficient to rescue cultures from MIC-level antifolate treatment. Instead of the “thymineless death” that characterizes folate pathway inhibition in a wide variety of organisms, these data suggest that M. tuberculosis is vulnerable to a critical disruption of the biosynthesis of methionine-derived compounds.
2014-03-19 | GSE55979 | GEO
Project description:WGS from National Public Health Laboratory, Tel-Aviv, submitted for WHO mutation catalogue 2023 version
| PRJNA1119380 | ENA
Project description:Tuberculosis (TB) is still a serious threat to human health which is caused by mycobacterium tuberculosis (Mtb). The main reason for failure to eliminate TB is lack of clearly understanding the molecular mechanism of Mtb pathogenesis. Determining human Mtb-interacting proteins enables us to characterize the mechanism and identify potential molecular targets for TB diagnosis and treatment. However, experimentally systematic Mtb interactors are not readily available. In this study, we performed an unbiased, comprehensive two-way proteome microarray based approach to systematically screen global human Mtb interactors and determine the binding partners of Mtb effectors. Our results, for the first time, screened 84 potential human Mtb interactors. Bioinformatic analysis further highlighted these protein candidates might engage in a wide range of cellular functions such as activation of DNA endogenous promoters, transcription of DNA/RNA and necrosis, as well as immune-related signaling pathways. Then, using Mtb proteome microarray followed His tagged pull-down assay and Co-IP, we identified one interacting partner (Rv0577) for the protein candidate NRF1 and three binding partners (Rv0577, Rv2117, Rv2423) for SMAD2, respectively. This study gives new insights into the profile of global Mtb interactors potentially involved in Mtb pathogenesis and demonstrates a powerful strategy in the discovery of Mtb effectors.
| S-EPMC6448480 | biostudies-literature